| Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention E Shirbhate, J Pandey, VK Patel,, M Kamal, T Jawaid, B Gorain, ... Pharmacological reports, 2021 | 88 | 2021 |
| Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers H Rajak, PK Dewangan, V Patel, DK Jain, A Singh, R Veerasamy, ... Current Pharmaceutical Design 19 (10), 1923-1955, 2013 | 81 | 2013 |
| Novel UV spectrophotometer methods for quantitative estimation of metronidazole and furazolidone using mixed hydrotropy solubilization R Jain, N Jain, DK Jain, VK Patel, H Rajak, SK Jain Arabian Journal of Chemistry 10 (2), 151-156, 2017 | 62 | 2017 |
| Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent VK Patel, E Shirbhate, P Patel, R Veerasamy, PC Sharma, H Rajak Beni-Suef University Journal of Basic and Applied Sciences 10, 2021 | 37 | 2021 |
| panobinostat as pan-deacetylase inhibitor for the treatment of pancreatic cancer: recent progress and future prospects A Singh, VK Patel, DK Jain, P Patel, H Rajak Oncology and Therapy 4, 73-89, 2016 | 36 | 2016 |
| Peptide based macrocycles: selective histone deacetylase inhibitors with antiproliferative activity. H Rajak, A Singh, PK Dewangan, V Patel, DK Jain, SK Tiwari, ... Current Medicinal Chemistry 201, 1887-1903, 2013 | 35 | 2013 |
| The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and … A Singh, P Patel, Jageshwar, VK Patel, DK Jain, M Kama, H Rajak Current Cancer Drug Targets 18, 720-736, 2018 | 23 | 2018 |
| Pharmacophore based 3D-qsar, virtual screening and docking studies on novel series of HDAC inhibitors with thiophen linker as anticancer agents P Patel, A Singh, VK Patel, DK Jain, R Veerasamy, H Rajak Combinatorial chemistry & high throughput screening 19 (9), 735-751, 2016 | 20 | 2016 |
| The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatment P Shirbhate, Ekta Patel, VK Patel, R Veerasamy, PC Sharma, R Harish FUTURE ONCOLOGY, 2020 | 18 | 2020 |
| Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects A Singh, P Patel, VK Patel, DK Jain, R Veerasamy, PC Sharma, H Rajak Current Cancer Drug Targets 17 (5), 456-466, 2017 | 18 | 2017 |
| Development of structure activity correlation model on Azetidin-2-ones as tubulin polymerization inhibitors VK Patel, KS Chouhan, A Singh, DK Jain, R Veerasamy, PK Singour, ... Letters in Drug Design & Discovery 12, 351-365, 2015 | 17 | 2015 |
| Assessment of 5-substituted isatin as surface recognition group: design, synthesis, and antiproliferative evaluation of hydroxamates as novel Histone Deacetylase inhibitors. A Singh, K Raghuwanshi, VK Patel, DK Jain, R Veerasamy, A Dixit, ... Pharmaceutical Chemistry Journal 51, 366-374, 2017 | 16 | 2017 |
| Synthesis, biological evaluation and molecular docking studies of 2-amino-3,4,5-trimethoxyaroylindole derivatives as novel anticancer agents VK Patel, H Rajak Bioorganic & Medicinal Chemistry Letters 26, 2115-2118, 2016 | 16 | 2016 |
| Hydroxamic acid based histone deacetylase inhibitors: present and future prospectives as anticancer agent DK Jain, A Singh, VK Patel, PC Sharma, A Gupta, A Sharma, H Rajak International Journal of Pharmacy and Pharmaceutical Sciences 6 (4), 648-50, 2014 | 15 | 2014 |
| Combretastatin A-4 based thiophene derivatives as antitumor agent: Development of structure activity correlation model using 3D-QSAR, pharmacophore and docking studies VK Patel, A Singh, DK Jain, P Patel, R Veerasamy, PC Sharma, H Rajak Future Journal of Pharmaceutical sciences 3, 71-78, 2017 | 13 | 2017 |
| Identification of Hydroxamic Acid Based Selective HDAC1 Inhibitors: Computer Aided Drug Design Studies P Patel, VK Patel, A Singh, T Jawaid, M Kamal, H Rajak Current Computer Aided Drug Design, 2019 | 12 | 2019 |
| Appraisal of pyrrole as connecting unit in hydroxamic acid based histone deacetylase inhibitors: Synthesis, anticancer evaluation and molecular docking studies A Singh, VK Patel, H Rajak Journal of Molecular Structure 1240, 130590, 2021 | 11 | 2021 |
| Significance of amino group substitution at combretastatin A-4 and phenstatin analogs VK Patel, H Rajak Letters in Drug Design & Discovery 13 (9), 943-951, 2016 | 11 | 2016 |
| Multi-targeted HDAC inhibitors as anticancer agents: Current status and future prospective VK Patel, E Shirbhate, P Tiwari, R Kore, R Veerasamy, A Mishra, H Rajak Current medicinal chemistry 30 (24), 2762-2795, 2023 | 10 | 2023 |
| Drug design strategies for the discovery of novel anticonvulsants concerned with four site binding pharmacophoric model studies DK Jain, A Singh, VK Patel, R Veerasamy, N Aggarwal, H Rajak Central Nervous System Agents in Medicinal Chemistry 17 (1), 30-50, 2017 | 10 | 2017 |
Anshuman DixitSenior Scientist, Institute of Life Sciences, Bhubaneswar, IndiaVerified email at ils.res.in
